| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.024 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.019 | 0.7 |